Why Even Good Hospitals And Doctors Are An Obstacle To Better, Cheaper Healthcare

As we noted in the context of antibiotics, it's well recognized that financial incentives cause the pharmaceutical industry to engage in research that tends to maximize profits rather than maximizing the health of the public. But a widely-circulated article in the Washington Post reveals another kind of bias that may stop us from adopting better ways of keeping people healthy that would also reduce healthcare costs. 

On Techdirt.

World Economic Forum Warns That Patents Are Making Us Lose The Race Against Antibiotic-Resistant Bacteria

Back in June last year, Techdirt reported on the warning from the World Health Organization's Director-General that we risked entering a "post-antibiotic era". That was in part because the current patent system was not encouraging the right kind of research by pharma companies in order to develop the new antibiotics that we desperately need. 

On Techdirt.

How Extending Patent Protection For Antibiotics Creates Perverse Incentives To Render Them Useless

We take antibiotics and their ability to kill practically all bacteria for granted. But scientists are increasingly warning that we may be about to leave what might come to be seen as a golden age for anti-bacterial drugs, and enter a post-antibiotic era. As the World Health Organization’s Director-General said, quoted in an article on the Citizen Vox site: 

On Techdirt.

The Tragedy of the Antibiotics Commons

Here's an interesting - and frightening - story that opened my eyes to something:

Studies in China show a "frightening" increase in antibiotic-resistant bacteria such as staphylococcus aureus bacteria, also know as MRSA . There are warnings that new strains of antibiotic-resistant bugs will spread quickly through international air travel and internation food sourcing.

"We have a lot of data from Chinese hospitals and it shows a very frightening picture of high-level antibiotic resistance," said Dr Andreas Heddini of the Swedish Institute for Infectious Disease Control.

"Doctors are daily finding there is nothing they can do, even third and fourth-line antibiotics are not working.

"There is a real risk that globally we will return to a pre-antibiotic era of medicine, where we face a situation where a number of medical treatment options would no longer be there. What happens in China matters for the rest of the world."

What this emphasises is that antibiotics form a kind of global commons - a resource whose benefits we all share. But if one party overexploits that commons - in this case, by recklessly handing out antibiotics as the article suggests - then the commons is ruined for *all* of us.

This development is yet another reason to get commons-based thinking into wider circulation - especially amongst the people making decisions, so that they can appreciate the massive global consequences that can flow from their apparently minor local actions.

Follow me @glynmoody on Twitter or identi.ca.

FDA Denies Evolution

Its seems the US FDA, like the equivalent European authorities before it, has decided to ignore evolution:

The government is on track to approve a new antibiotic to treat a pneumonia-like disease in cattle, despite warnings from health groups and a majority of the agency's own expert advisers that the decision will be dangerous for people.

The drug, called cefquinome, belongs to a class of highly potent antibiotics that are among medicine's last defenses against several serious human infections. No drug from that class has been approved in the United States for use in animals.

The American Medical Association and about a dozen other health groups warned the Food and Drug Administration that giving cefquinome to animals would probably speed the emergence of microbes resistant to that important class of antibiotics, as has happened with other drugs. Those super-microbes could then spread to people.